Hyperion Defi (HYPD) Other Working Capital Changes (2017 - 2026)
Hyperion Defi (HYPD) posted quarterly Other Working Capital Changes of -$120938.0 for Q1 2026, up 20.66% year-over-year from -$100227.8 in Q1 2025, and down 2.64% quarter-over-quarter from -$117827.0 in Q4 2025.
Hyperion Defi (HYPD) Other Working Capital Changes (2017 - 2026) Analysis & Trends
Hyperion Defi (HYPD) has reported Other Working Capital Changes for 7 consecutive years, with -$120938.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Working Capital Changes rose 20.66% year-over-year to -$120938.0; the TTM figure through Mar 2026 stood at -$542562.0 (up 6.39% YoY), while the FY2025 annual figure was -$574060.0, down 14.53% from the prior year.
- Other Working Capital Changes fell to -$120938.0 in Q1 2026 per HYPD's latest filing, from -$117827.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $1.5 million in Q1 2026 and bottomed at -$573427.0 in Q2 2024.
- Historically, Other Working Capital Changes has averaged $28887.8 across 5 years, with a median of -$104419.0 in 2025.
- Annual changes were most pronounced in 2022 — Other Working Capital Changes soared 104.59% — and 2023, when it tumbled 360.09%.
- Hyperion Defi's Other Working Capital Changes stood at -$463383.0 in 2022, then jumped by 80.19% to -$91780.0 in 2023, then slumped by 61.71% to -$148414.0 in 2024, then advanced by 20.61% to -$117827.0 in 2025, then slipped by 2.64% to -$120938.0 in 2026.
- Business Quant data shows HYPD's Other Working Capital Changes at -$120938.0 in Q1 2026, -$117827.0 in Q4 2025, and -$114416.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Hyperion Defi | 44.93 Mn | 35.29 Mn | 357,693.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 368,146.00 |
| Jun 30, 2026 | 368,146.00 |
| Jun 30, 2026 | 368,146.00 |
| Mar 31, 2026 | 1.54 Mn |
| Mar 31, 2026 | 1.54 Mn |
| Mar 31, 2026 | 1.54 Mn |
| Dec 31, 2025 | -60,245.00 |
| Dec 31, 2025 | -60,245.00 |
| Dec 31, 2025 | -60,245.00 |
| Sep 30, 2025 | -104,419.00 |
| Sep 30, 2025 | -104,419.00 |
| Sep 30, 2025 | -104,419.00 |
| Jun 30, 2025 | -256,051.00 |
| Jun 30, 2025 | -256,051.00 |
| Jun 30, 2025 | -256,051.00 |
| Mar 31, 2025 | 577,321.00 |
| Mar 31, 2025 | 577,321.00 |
| Mar 31, 2025 | 577,321.00 |
| Dec 31, 2024 | 282,487.00 |
| Dec 31, 2024 | 282,487.00 |